Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 28;97(2):523–545. doi: 10.1007/s00204-022-03436-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 3 — Cell viability assessment after DCVGs and DCVCs exposure. Measurements were performed after 24 h exposure of eleven concentrations (0.03, 0.09, 0.29, 0.9, 2.9, 9.3, 29.7, 62.5, 125, 250, 500) of indicated TCE conjugates in the six human cell models tested. Viability in HUVEC/TERT2, HepaRG and RPTEC/TERT1 was assessed by resazurin reduction. Viability and neurite area in LUHMES and UKN5 were assessed with Calcein-AM and H-33342 staining. ATP content was used as viability parameter in BCC42 cells. Values represent the mean % medium control ± SD for each different assay. Untr: untreated samples were used as negative controls. a 1,2-DCVC, b 1,2-DCVG, c 2,2-DCVC, d 2,2-DCVG

Fig. 3 — Cell viability assessment after DCVGs and DCVCs exposure. Measurements were performed after 24 h exposure of eleven concentrations (0.03, 0.09, 0.29, 0.9, 2.9, 9.3, 29.7, 62.5, 125, 250, 500) of indicated TCE conjugates in the six human cell models tested. Viability in HUVEC/TERT2, HepaRG and RPTEC/TERT1 was assessed by resazurin reduction. Viability and neurite area in LUHMES and UKN5 were assessed with Calcein-AM and H-33342 staining. ATP content was used as viability parameter in BCC42 cells. Values represent the mean % medium control ± SD for each different assay. Untr: untreated samples were used as negative controls. a 1,2-DCVC, b 1,2-DCVG, c 2,2-DCVC, d 2,2-DCVG